Efficacy and safety of Shugan Jieyu Capsule in the treatment of depressive state after acute coronary syndrome: study protocol for a multicenter randomized controlled trial
This trial will evaluate the efficacy and safety of SGJY in managing depressive state after ACS. Additionally, the potential of SGJY to improve long-term prognosis in patients with depressive state after ACS will be assessed.
Authors
- Qiaoning Yang (ORCID: https://orcid.org/0000-0001-5861-5778)
- Zhuang Cui (ORCID: https://orcid.org/0000-0001-6495-766X)
- Yankai Yang (ORCID: https://orcid.org/0009-0003-7320-3941)
- Yanqiao Yu (ORCID: https://orcid.org/0000-0002-1393-4019)
- Xiaodi Fan (ORCID: https://orcid.org/0000-0002-5004-7099)
- Rui-Na Bai
- Furong Yang
- Yajie Cai
Institutions
- Beijing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Xiyuan Hospital (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-10-16
- DOI
- https://doi.org/10.3389/fpsyt.2025.1683736
- Primary Topic
- Cardiac Health and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00